<DOC>
	<DOC>NCT00768638</DOC>
	<brief_summary>Randomized controlled double blind study of parallel groups to evaluate the comparative effects of low-dose of atorvastatin on proteinuria in patients with stage 3 or 4 chronic kidney disease.</brief_summary>
	<brief_title>Study of Atorvastatin Dose Dependent Reduction of Proteinuria</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Age of 18 and over Stage 3 or 4 chronic kidney disease (modified MDRD) proteinuria of &gt; 1g/d on ACEi and/or ARB, or proteinuria of &gt; 1g/d with intolerance or contraindication to ACEi and/or ARB blood pressure &lt; 130/80 mmHg or &lt; 140/90 mmHg in patients with five or more antihypertensive drugs stable renal function rapid progression of renal failure immunosuppressive therapy within the past 3 months need a renal replacement therapy within 8 months definite history of chronic liver disease, or abnormal liver function evidence of active inflammatory muscle disease definite previous adverse reaction to a statin concurrent treatment with a contraindicated drug (fibrate, macrolide antibiotic, systemic use of imidazole or triazole antifungals, proteaseinhibitors, ciclosporin) child bearing potential known to be poorly compliant with clinic visits or prescribed medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Chronic kidney disease</keyword>
</DOC>